lip10-2 (+ megacomplex)
Description
Technical info
Tilt Series Date: 2020-09-29
Data Taken By: William Nicolas
Species / Specimen: Escherichia coli
Strain: PK2, BL21 dHisdHA RQABpCDF+EFGpRSF
Tilt Series Settings: Single Axis, tilt range: (-60.0°, 60.0°), step: 2°, constant angular increment, dosage: 56.0 eV/Ų, defocus: -8.0 μm, magnification: 11000x.
Microscope: IECB Talos Artica
Acquisition Software: Serial EM
Upload Method: pipeline
Processing Software Used: Raptor
Collaborators and Roles: Petya Krasteva (head of the SBB lab at the IECB, Bordeaux° and Wiem . Abidi (graduate student) did the preps and helped with acquisition
Purification / Growth Conditions / Treatment: BL21 cells were transformed with QAB - pCDF plasmid and EFG - pRSF . plasmid to express the inner-membrane macro-complex.. . Selection done with Kanamycin and Streptomycin.. . Induction of expression ON done with IPTG. . Spheroplasts are generated from the BL21 non transformed cells cells.. Spheroplasts are processed through a high-pressure homogenizer and . further purification by ultracentrifugation of the membrane . fractions. . Liposomes are then generated from the membrane fractions by . processing through Potter and sonicator..
Sample Preparation: Fiducials were prepared my method (see lab archive). . Grids: Quantifoil Cu NH2 R2/2. . Glowdischarged 3mA - 2min. BT3s - BF0. 4uL pipetted on the grids
Attached Files
lip10-2-sq1-tg8.mrc, Tilt Series (Pixel Size 0.39 nm), 1.7 GB
lip10-2-sq1-tg8_full.rec, Reconstruction (Pixel Size 0.78 nm), 1.8 GB
Files
keyimg_wnj2020-09-29-19.jpg
Additional details
Identifiers
- DOI
- 10.22002/qm09s-43584
- TILT_SERIES_ID
- wnj2020-09-29-19
Funding
- NIH
- HHMI
- Beckman Institute
- Gordon and Betty Moore Foundation
- Agouron Institute
- John Templeton Foundation
Dates
- Collected
-
2020-09-29
- Created
-
2020-11-16
- Updated
-
2020-11-20